Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Danesi

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy and Pharmacology|January 29, 1999
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivoG Bocci, R Danesi, U Benelli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in miceF Innocenti, R Danesi, A Di Paolo, et al.
Ultrastructural Pathology|October 30, 1998
Ultrastructural and biochemical evidence of apoptosis induced by a novel inhibitor of protein geranylgeranylation in human MIA PaCa-2 pancreatic cancer cellsM Gesi, A Pellegrini, P Soldani, et al.
Journal of Chemotherapy (Florence, Italy)|January 26, 2006
Idarubicin and idarubicinol effects on breast cancer multicellular spheroidsP Orlandi, C Barbara, G Bocci, et al.
Seminars in Oncology|March 4, 2000
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancerA Gennari, S Donati, R Danesi, et al.
Cancer|January 15, 1995
Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II studyA Falcone, E Pfanner, C Cianci, et al.
Pharmacological Research|September 1, 1995
Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell linesA di Paolo, G Bocci, F Innocenti, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|January 1, 1994
Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicinA Pinna, C Agen, A Di Paolo, et al.
British Journal of Cancer|June 1, 1993
Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferationN Bernardini, F Giannessi, F Bianchi, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 19, 2026
Histopathological predictive factors of sentinel node positivity in melanoma in the Blumenau-SC Brazilian regionR Kraft Rovere, V D de Almeida, C H de Freitas, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|January 29, 1999
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivoG Bocci, R Danesi, U Benelli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in miceF Innocenti, R Danesi, A Di Paolo, et al.
Ultrastructural Pathology|October 30, 1998
Ultrastructural and biochemical evidence of apoptosis induced by a novel inhibitor of protein geranylgeranylation in human MIA PaCa-2 pancreatic cancer cellsM Gesi, A Pellegrini, P Soldani, et al.
Journal of Chemotherapy (Florence, Italy)|January 26, 2006
Idarubicin and idarubicinol effects on breast cancer multicellular spheroidsP Orlandi, C Barbara, G Bocci, et al.
Seminars in Oncology|March 4, 2000
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancerA Gennari, S Donati, R Danesi, et al.
Cancer|January 15, 1995
Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II studyA Falcone, E Pfanner, C Cianci, et al.
Pharmacological Research|September 1, 1995
Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell linesA di Paolo, G Bocci, F Innocenti, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|January 1, 1994
Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicinA Pinna, C Agen, A Di Paolo, et al.
British Journal of Cancer|June 1, 1993
Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferationN Bernardini, F Giannessi, F Bianchi, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 19, 2026
Histopathological predictive factors of sentinel node positivity in melanoma in the Blumenau-SC Brazilian regionR Kraft Rovere, V D de Almeida, C H de Freitas, et al.
Pageof 16